Iron trichloride-promoted cyclization of o-alkynylaryl lsocyanates: synthesis of 3-(chloromethylene)oxindoles

Organic Letters

Volumn 11, Issue 19, 2009, Pages 4262-4265

  Cantagrel, Guillaume ^a   De Carné Carnavalet, Benoît ^a   Meyer, Christophe ^a   Cossy, Janine ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; FERRIC CHLORIDE; FERRIC ION; INDOLE DERIVATIVE; ISOCYANIC ACID DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; STEREOISOMERISM; SYNTHESIS;

CHLORIDES; CYCLIZATION; FERRIC COMPOUNDS; INDOLES; ISOCYANATES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 70350137303     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol9014877     Document Type: Article

References (67)

1. (a) Sarges, R.; Howard, H. R.; Koe, B. K.; Weissman, A. J. Med. Chem. 1989, 32, 437-444.
2. (b) Sun, L.; Tran, N.; Liang, C.; Tang, F.; Rice, A.; Schreck, R.; Waltz, K.; Shawver, L. K.; McMahon, G.; Tang, C. J. Med. Chem. 1999, 42, 5120-5130.
3. (c) Sun, L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Cui, J.; Fukuda, J. Y.; Chu, J.-Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla, A.; Luu, T. C.; Tang, F; Wei, J.; Tang, C. J. Med. Chem. 2003,46, 1116-1119.
4. (d) Pandit, B.; Sun, Y.; Chen, P.; Sackett, D. L.; Hu, Z.; Rich, W.; Li, C.; Lewis, A.; Schaefer, K.; Li, P.-K. Bioorg. Med. Chem. 2006, 14, 6492-6501.
5. (e) Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Kunkel, M. W. J. Med. Chem. 2006, 49, 6922-6924.
6. (f) Sun, L.; Tran, N.; Tang, F.; App, H.; Hirth, P.; McMahon, G.; Tang, C. J. Med. Chem. 1998, 41, 2588-2603.
7. (g) Yang, T.-M.; Liu, G. J. Comb. Chem. 2007, 9, 86-95.
8. Teichert, A.; Jantos, K.; Harms, K.; Studer, A. Org. Lett. 2004, 6, 3477-3480.
9. (a) Mori, M.; Ban, Y. Tetrahedron Lett. 1979, 13, 1133-1136.
10. (b) Arumugam, V.; Routledge, A.; Abell, C.; Balasubramanian, S. Tetrahedron Lett. 1997, 38, 6473-6476.
11. (c) Dai, W.-M.; Shi, J.; Wu, J. Synlett 2008, 2716-2720.
12. Bowman, W. R.; Heaney, H.; Jordan, B. M. Tetrahedron Lett. 1988, 29, 6657-6660.
13. (a) D'Souza, D. M.; Rominger, F.; Müller, T. J. J. Angew. Chem., Int. Ed. 2005, 44, 153-158.
14. (b) Cheung, W. S.; Patch, R. J.; Player, M. R. J. Org. Chem. 2005, 70, 3741-3744.
15. (c) Yanada, R.; Obika, S.; Inokuma, T.; Yanada, K.; Yamashita, M.; Ohta, S.; Takemoto, Y. J. Org. Chem. 2005, 70, 6972-6975.
16. (d) Aithuis, M.; Pontikis, R.; Florent, J.-C. Tetrahedron Lett. 2007, 48, 6397-6400.
17. Yanada, R.; Obika, S.; Oyama, M.; Takemoto, Y. Org. Lett. 2004, 6, 2825-2828.
18. Shintani, R.; Yamagami, T.; Hayashi, T. Org. Lett. 2006, 8, 4799-4801.
19. (a) Pinto, A.; Neuville, L.; Retailleau, P.; Zhu, J. Org. Lett. 2006, 8, 4927-4930.
20. (b) Pinto, A.; Neuville, L.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 3291-3295.
21. (c) Tang, S.; Peng, P.; Zhong, P.; Li, J.-H. J. Org. Chem. 2008, 73, 5476-5480.
22. (a) Hirao, K.; Morii, N.; Joh, T.; Takahashi, S. Tetrahedron Lett. 1995, 36, 6243-6246.
23. (b) Park, J. H.; Kim, E.; Chung, Y. K. Org. Lett. 2008, 10, 4719-4721.
24. Fielding, M. R.; Grigg, R.; Urch, C. J. Chem. Commun. 2000, 2239-2240.
25. (a) Miura, T.; Takahashi, Y.; Murakami, M. Org. Lett. 2007, 9, 5075-5077.
26. (b) Miura, T.; Takahashi, Y.; Murakami, M. Org. Lett. 2008, 10, 1743-1745.
27. Kamijo, S.; Sasaki, Y.; Kanazawa, C.; Schüsseler, T.; Yamamoto, Y. Angew. Chem., Int. Ed. 2005, 44, 7718-7721.
28. (a) Treu, M.; Guertler, U.; Karner, T. Kraemer, O.; Quant, J. J.; Zahn, S. K. (Boehringer Ingelheim. Int.) WO 200815 2013 Al, Dec 18, 2008.
29. (b) Treu, M.; Mantoulidis, A.; Tontsch-Grunt, U. (Boehringer Ingelheim. Int.) WO2007122219 Al, Nov 1, 2007.
30. (c) Heckel, A.; Roth, G. J.; Joerg, K.; Hoerer, S.; Uphues, I. (Boehringer Ingelheim Int.) US20050203104 Al, Sep 15, 2005.
31. (d) Burgdorf, L. T.; Bruge, D.; Greiner, H.; Kordowicz, M.; Sirrenberg, C.; Zenke, F. (Merck Patent) WO2006131186 Al, Dec 2006, 14.
32. (e) Kley, J.; Heckel, A.; Hilberg, F.; Roth, G. J.; LehmannLintz, T.; Lotz, R. R. H.; Tontsch-Grunt, U.; Van. Meel, J. C. A. (Boehringer Ingelheim Pharma) WO2004026829 A2, April 2004, 1.
33. Lu, B.; Ma, D. Org. Lett. 2006, 8, 6115-6118.
34. (a) Tang, S.; Peng, P.; Pi, S.-F.; Liang, Y.; Wang, N.-X.; Li, J.-H. Org. Lett. 2008, 10, 1179-1182.
35. (b) Tang, S.; Peng, P.; Wang, Z.-Q.; Tang, B.-X.; Deng, C.-L.; Li, J.-H.; Zhong, P.; Wang, N.-X. Org. Lett. 2008, 10, 1875-1878.
36. (c) Peng, P.; Tang, B.-X.; Pi, S.-F.; Liang, Y.; Li, J.-H. J. Org. Chem. 2009, 74, 3569-3572.
37. Miura, T.; Toyoshima, T.; Takahashi, Y.; Murakami, M. Org. Lett. 2009, 11, 2141-2143.
38. (a) Beccalli, E. M.; Marchesini, A.; Pilati, T. Tetrahedron 1994, 50, 12697-12712.
39. (b) Beccalli, E. M.; Marchesini, A. Tetrahedron 1995, 51, 2353-2362.
40. Tang, S.; Yu, Q.-F.; Peng, P.; Li, J.-H.; Zhong, P.; Tang, R.-Y. Org. Lett. 2007, 9, 3413-3416.
41. For examples, see: (a) Vamey, M. D.; Marzoni, G. P.; Palmer, C. L.; Deal, J. G.; Webber, S.; Welsh, K. M.; Bacquet, R. J.; Bartlett, C. A.; Morse, C. A.; Booth, C. L. J.; Herrmann, S. M.; Howland, E. F.; Ward, R. W.; White, J. J. Med. Chem. 1992, 35, 663-676.
42. (b) Smith, A. B., III.; Cantin, L.-D.; Pasternak, A.; Guise-Zawacki, L.; Yao, W.; Charnley, A. K.; Barbosa, J.; Sprengeler, P. A.; Hirschmann, R.; Munshi, S.; Olsen, D. B.; Schleif, W. A.; Kuo, L. C. J. Med. Chem. 2003, 46, 1831-1844.
43. (c) Afarinkia, K.; Ndibwami, A. Synlett 2007, 1940-1944.
44. (d) Hanessian, S.; Demont, E.; van Otterlo, W. A. L. Tetrahedron Lett. 2000, 41, 4999-5003.
45. (e) Ohta, S.; Kimoto, S. Chem. Pharm. Bull. 1976, 24, 2969-2976.
46. (f) Balázs, L.; Nyerges, M.; Kádas, I.; Töke, L. Synthesis 1995, 1373-1375.
47. (g) Umezawa, B.; Hoshino, O.; Sawaki, S.; Mori, K. Chem. Pharm. Bull. 1980, 28, 1003-1005.
48. (h) Fevig, T. L.; Bowen, S. M.; Janowick, D. A.; Jones, B. K.; Munson, H. R.; Ohlwiler, D. F.; Thomas, C. E. J. Med. Chem. 1996, 39, 4988-4996.
49. (i) Irie, H.; Shiina, A.; Fushimi, T.; Katakawa, J.; Fujii, N.; Yajima, H. Chem. Lett. 1980, 875-878.
50. (j) Katakawa, J.; Yoshimatsu, H.; Yoshida, M.; Zhang, Y.; Irie, H.; Yajima, H. Chem. Pharm. Bull., 1988, 36, 3928-3932.
51. (k) Anderson, W. K.; Heider, A. R.; Raju, N.; Yucht, J. A. J. Med. Chem. 1988, 31, 2097-2102.
52. Recently, TfOH-promoted tandem Friedel-Crafts alkenylationcyclization of 2-alkynylphenyl isothiocyanates has been disclosed; see: Otani, T.; Kunimatsu, S.; Takahashi, T.; Nihei, H.; Saito, T. Tetrahedron Lett. 2009, 50, 3853-3856.
53. Bolm, C.; Legros, J.; Le Paih, J.; Zani, L. Chem. Rev. 2004, 104, 6217-6254.
54. (a) Miranda, P. O.; Díaz, D. D.; Padrón, J. I.; Bermejo, J.; Martín, V. S. Org. Lett. 2003, 5,1979-1982.
55. (b) Miranda, P. O.; Díaz, D. D.; Padrón, J. I.; Ramírez, M. A.; Martín, V. S. J. Org. Chem. 2005, 70, 57-62.
56. (c) Xu, T.; Yu, Z.; Wang, L. Org. Lett. 2009, 11, 2113-2116.
57. (a) Yamazaki, S.; Yamada, K.; Yamabe, S.; Yamamoto, K. J. Org. Chem. 2007, 67, 2889-2901.
58. (b) Snider, B. B.; Roush, D. M. J. Org. Chem. 1979, 44, 4229-4232.
59. 1H NMR. The chemical shift of the aromatic proton H4 serves as a reliable diagnostic for the configurational assignment; see the Supporting Information.
60. See the Supporting Information.
61. A few examples of such reactions have been previously reported, with 3-(chlorometh.ylene)oxindoles bearing an acyl group on the nitrogen, by heating with an amine. Enol ethers derived from 3-acyloxindoles have been more extensively used as substrates.
62. Kappe, C. O. Angew. Chem., Int. Ed. 2004, 43, 6250-6284.
63. Treatment of la under similar conditions [piperidine (2 equiv), EtOH, microwave, 150 °C, 0.3 h] only led to the corresponding ethyl carbamate (55%) and urea (45%) resulting from addition of ethanol and piperidine, respectively, to the isocyanate.
64. The chemical shift of the oxindole proton H4 (5.32-6.30 ppm) supported the Z configuration of those compounds, and the configuration of 14 was unambiguously confirmed by NMR (NOE).
65. (a) Ito, Y.; Fujii, S.; Saegusa, T. J. Org. Chem. 1976, 41, 2073-2074.
66. (b) Blanco, L.; Mansouri, A. Tetrahedron Lett. 1988, 29, 3239-3242.
67. max = 511 nm).